CorAlert has developed an accurate and easy-to-use device for measuring left ventricular end-diastolic pressure (LVEDP) in real-time, which is an important index for assessing the severity of heart failure. This non-invasive device provides physicians with a comprehensive hemodynamic profile, allowing them to accurately determine the type and severity of heart failure. The device also enables long-term trend analysis and prediction of patient prognosis through a cloud application. CorAlert conducted a successful clinical trial comparing their device to invasive measurements, showing a strong correlation. The company has completed production of their Beta model and is currently conducting a clinical trial in Israel.